The routes those studies used and the routes people are buying dont overlap much: The FDA states it plainly: We found no studies that administered BPC-157 to humans via the proposed oral, SC, nasal, or transdermal ROA. Is BPC-157 FDA approved
Likewise, their adjacent colon relatively far from anastomosis, but with colitis, could sustain only a very small amount of the infunded water ( Fig
: , DSIP
The high-energy terahertz range disrupts iron-transport protein interactions, reducing intracellular Fe 2+ availability
the rest is mechanistic reasoning that a clinician should weigh individually: Known copper or peptide allergy the most concrete contraindication, explicit enough that clinical researchers screen it out (NCT07437586)
It carries an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, giving it 83 amino acids total versus 70 for native IGF-1